| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 3.17e-05 | 43 | 84 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 1.59e-04 | 192 | 84 | 6 | GO:0008234 | |
| GeneOntologyBiologicalProcess | siRNA-mediated heterochromatin formation | 1.01e-05 | 11 | 83 | 3 | GO:0141194 | |
| GeneOntologyBiologicalProcess | transposable element silencing by siRNA-mediated heterochromatin formation | 1.01e-05 | 11 | 83 | 3 | GO:0141007 | |
| GeneOntologyBiologicalProcess | transposable element silencing by heterochromatin formation | 4.91e-05 | 18 | 83 | 3 | GO:0141005 | |
| GeneOntologyBiologicalProcess | ectopic germ cell programmed cell death | 7.93e-05 | 21 | 83 | 3 | GO:0035234 | |
| GeneOntologyBiologicalProcess | piRNA processing | 9.16e-05 | 22 | 83 | 3 | GO:0034587 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA-mediated heterochromatin formation | 1.05e-04 | 23 | 83 | 3 | GO:0031048 | |
| HumanPheno | Perifollicular hyperkeratosis | 1.08e-06 | 4 | 34 | 3 | HP:0007468 | |
| HumanPheno | Abnormal perifollicular morphology | 5.36e-06 | 6 | 34 | 3 | HP:0031285 | |
| MousePheno | abnormal Purkinje cell dendrite morphology | 1.17e-05 | 58 | 72 | 5 | MP:0008572 | |
| Domain | TPR_REGION | 7.03e-07 | 165 | 83 | 8 | PS50293 | |
| Domain | TPR | 7.03e-07 | 165 | 83 | 8 | PS50005 | |
| Domain | Coatomer/calthrin_app_sub_C | 4.66e-06 | 8 | 83 | 3 | IPR009028 | |
| Domain | - | 1.95e-05 | 2 | 83 | 2 | 2.60.40.1150 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 1.95e-05 | 2 | 83 | 2 | IPR013037 | |
| Domain | TPR | 2.36e-05 | 129 | 83 | 6 | SM00028 | |
| Domain | TPR_repeat | 2.80e-05 | 133 | 83 | 6 | IPR019734 | |
| Domain | Clathrin/coatomer_adapt-like_N | 3.70e-05 | 15 | 83 | 3 | IPR002553 | |
| Domain | Adaptin_N | 3.70e-05 | 15 | 83 | 3 | PF01602 | |
| Domain | - | 3.78e-05 | 207 | 83 | 7 | 1.25.40.10 | |
| Domain | TPR_1 | 5.02e-05 | 90 | 83 | 5 | PF00515 | |
| Domain | TPR_1 | 5.02e-05 | 90 | 83 | 5 | IPR001440 | |
| Domain | TPR-contain_dom | 5.51e-05 | 150 | 83 | 6 | IPR013026 | |
| Domain | AP_complex_bsu_1_2_4 | 5.84e-05 | 3 | 83 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 5.84e-05 | 3 | 83 | 2 | PF09066 | |
| Domain | TPR-like_helical_dom | 7.98e-05 | 233 | 83 | 7 | IPR011990 | |
| Domain | B-adaptin_app_sub_C | 1.16e-04 | 4 | 83 | 2 | IPR015151 | |
| Domain | Taxilin | 1.16e-04 | 4 | 83 | 2 | PF09728 | |
| Domain | B2-adapt-app_C | 1.16e-04 | 4 | 83 | 2 | SM01020 | |
| Domain | ARM-type_fold | 1.31e-04 | 339 | 83 | 8 | IPR016024 | |
| Domain | Keratin_2_head | 1.60e-04 | 24 | 83 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 1.60e-04 | 24 | 83 | 3 | PF16208 | |
| Domain | AP_beta | 1.93e-04 | 5 | 83 | 2 | IPR026739 | |
| Domain | Keratin_II | 2.04e-04 | 26 | 83 | 3 | IPR003054 | |
| Domain | DUSP | 2.89e-04 | 6 | 83 | 2 | SM00695 | |
| Domain | DUSP | 2.89e-04 | 6 | 83 | 2 | PF06337 | |
| Domain | Beta2_adaptin/TBP_C_dom | 2.89e-04 | 6 | 83 | 2 | IPR012295 | |
| Domain | - | 2.89e-04 | 6 | 83 | 2 | 3.30.310.10 | |
| Domain | Tudor | 3.15e-04 | 30 | 83 | 3 | IPR002999 | |
| Domain | - | 4.04e-04 | 7 | 83 | 2 | 3.30.2230.10 | |
| Domain | DUSP | 4.04e-04 | 7 | 83 | 2 | PS51283 | |
| Domain | Pept_C19_DUSP | 4.04e-04 | 7 | 83 | 2 | IPR006615 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 6.88e-04 | 9 | 83 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 6.88e-04 | 9 | 83 | 2 | PF02883 | |
| Domain | Alpha_adaptinC2 | 6.88e-04 | 9 | 83 | 2 | SM00809 | |
| Domain | Elongated_TPR_rpt_dom | 1.05e-03 | 11 | 83 | 2 | IPR023114 | |
| Domain | ZnF_UBP | 1.05e-03 | 11 | 83 | 2 | SM00290 | |
| Domain | Armadillo | 1.19e-03 | 47 | 83 | 3 | IPR000225 | |
| Domain | Coatomer/clathrin_app_Ig-like | 1.25e-03 | 12 | 83 | 2 | IPR013041 | |
| Domain | TPR_2 | 1.43e-03 | 50 | 83 | 3 | PF07719 | |
| Domain | TPR_2 | 1.43e-03 | 50 | 83 | 3 | IPR013105 | |
| Domain | TUDOR | 1.72e-03 | 14 | 83 | 2 | PF00567 | |
| Domain | Znf_UBP | 1.72e-03 | 14 | 83 | 2 | IPR001607 | |
| Domain | zf-UBP | 1.72e-03 | 14 | 83 | 2 | PF02148 | |
| Domain | ZF_UBP | 1.72e-03 | 14 | 83 | 2 | PS50271 | |
| Domain | PI3/4_kinase_CS | 1.97e-03 | 15 | 83 | 2 | IPR018936 | |
| Domain | - | 2.25e-03 | 16 | 83 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.25e-03 | 16 | 83 | 2 | SM00146 | |
| Domain | Intermediate_filament_CS | 2.77e-03 | 63 | 83 | 3 | IPR018039 | |
| Domain | PI3/4_kinase_cat_dom | 2.85e-03 | 18 | 83 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.85e-03 | 18 | 83 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.85e-03 | 18 | 83 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.85e-03 | 18 | 83 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.85e-03 | 18 | 83 | 2 | PS00916 | |
| Domain | - | 3.11e-03 | 222 | 83 | 5 | 1.25.10.10 | |
| Domain | USP_CS | 3.17e-03 | 66 | 83 | 3 | IPR018200 | |
| Domain | LIM | 3.59e-03 | 69 | 83 | 3 | PF00412 | |
| Domain | - | 3.74e-03 | 70 | 83 | 3 | 2.10.110.10 | |
| Domain | USP_1 | 3.74e-03 | 70 | 83 | 3 | PS00972 | |
| Domain | Znf_LIM | 3.89e-03 | 71 | 83 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 3.89e-03 | 71 | 83 | 3 | PS00478 | |
| Domain | UCH | 3.89e-03 | 71 | 83 | 3 | PF00443 | |
| Domain | USP_2 | 3.89e-03 | 71 | 83 | 3 | PS00973 | |
| Domain | LIM_DOMAIN_2 | 3.89e-03 | 71 | 83 | 3 | PS50023 | |
| Domain | Filament | 3.89e-03 | 71 | 83 | 3 | SM01391 | |
| Domain | LIM | 3.89e-03 | 71 | 83 | 3 | SM00132 | |
| Domain | IF | 4.05e-03 | 72 | 83 | 3 | PS00226 | |
| Domain | USP_3 | 4.05e-03 | 72 | 83 | 3 | PS50235 | |
| Domain | USP_dom | 4.05e-03 | 72 | 83 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 4.05e-03 | 72 | 83 | 3 | IPR001394 | |
| Domain | Filament | 4.21e-03 | 73 | 83 | 3 | PF00038 | |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.41e-08 | 3 | 85 | 3 | 25557232 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.41e-08 | 3 | 85 | 3 | 1372089 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 1712823 | ||
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 1.62e-08 | 12 | 85 | 4 | 10692104 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 15797458 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 9707615 | ||
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 5.91e-08 | 16 | 85 | 4 | 15085952 | |
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 1.25e-07 | 19 | 85 | 4 | 21285247 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 11536012 | ||
| Pubmed | 5.00e-07 | 284 | 85 | 8 | 29459677 | ||
| Pubmed | 4.20e-06 | 266 | 85 | 7 | 19380743 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34749292 | ||
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 5.90e-06 | 2 | 85 | 2 | 15744029 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 37131223 | ||
| Pubmed | Expression of BAP1 and ATM proteins: Association with AJCC tumor category in uveal melanoma. | 5.90e-06 | 2 | 85 | 2 | 31864162 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26856463 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36057231 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9665406 | ||
| Pubmed | Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2. | 5.90e-06 | 2 | 85 | 2 | 21493713 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19779458 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9402962 | ||
| Pubmed | Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins. | 5.90e-06 | 2 | 85 | 2 | 33792613 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 39434144 | ||
| Pubmed | Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice. | 5.90e-06 | 2 | 85 | 2 | 24248351 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 14716300 | ||
| Pubmed | Artemis-dependent DNA double-strand break formation at stalled replication forks. | 5.90e-06 | 2 | 85 | 2 | 23465063 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22730303 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21596788 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.01e-06 | 281 | 85 | 7 | 28706196 | |
| Pubmed | Rapamycin Inhibited Pyroptosis and Reduced the Release of IL-1β and IL-18 in the Septic Response. | 1.77e-05 | 3 | 85 | 2 | 32851082 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23836881 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 38154620 | ||
| Pubmed | TDRD5 binds piRNA precursors and selectively enhances pachytene piRNA processing in mice. | 1.77e-05 | 3 | 85 | 2 | 29317670 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12056827 | ||
| Pubmed | NudC-like protein 2 restrains centriole amplification by stabilizing HERC2. | 1.77e-05 | 3 | 85 | 2 | 31427565 | |
| Pubmed | Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2. | 1.77e-05 | 3 | 85 | 2 | 24855649 | |
| Pubmed | Microparticulate P2X7 and GSDM-D mediated regulation of functional IL-1β release. | 1.77e-05 | 3 | 85 | 2 | 30547277 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27433030 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 21147755 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 38134572 | ||
| Pubmed | The tumor suppressor, TAX1BP2, is a novel substrate of ATM kinase. | 1.77e-05 | 3 | 85 | 2 | 24240686 | |
| Pubmed | HERC2-USP20 axis regulates DNA damage checkpoint through Claspin. | 1.77e-05 | 3 | 85 | 2 | 25355518 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 7958843 | ||
| Pubmed | Sequence data and chromosomal localization of human type I and type II hair keratin genes. | 1.77e-05 | 3 | 85 | 2 | 7556444 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 37185170 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12865408 | ||
| Pubmed | IL-1β turnover by the UBE2L3 ubiquitin conjugating enzyme and HECT E3 ligases limits inflammation. | 1.77e-05 | 3 | 85 | 2 | 37474493 | |
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 1.77e-05 | 3 | 85 | 2 | 9084137 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23935506 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 35303042 | ||
| Pubmed | 1.77e-05 | 63 | 85 | 4 | 16831889 | ||
| Pubmed | ZFP628 Is a TAF4b-Interacting Transcription Factor Required for Mouse Spermiogenesis. | 1.82e-05 | 21 | 85 | 3 | 31932482 | |
| Pubmed | AP4E1 GAPDH TRPM7 SLFN13 ZC3H4 PI4KA ADAMTS16 CNKSR2 MPHOSPH9 ADD3 | 2.02e-05 | 777 | 85 | 10 | 35844135 | |
| Pubmed | DAB2IP MAP2K4 AP1B1 AP2B1 UBE3A ZC3H4 PI4KA CNKSR2 HERC2 EPB41L1 WDR47 | 2.28e-05 | 963 | 85 | 11 | 28671696 | |
| Pubmed | 2.69e-05 | 70 | 85 | 4 | 34255829 | ||
| Pubmed | 2.85e-05 | 493 | 85 | 8 | 15368895 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CUL2 AP2B1 KRT81 CNKSR2 MPHOSPH9 UNC45A HERC2 FEM1A USP20 USP33 BAP1 | 3.37e-05 | 1005 | 85 | 11 | 19615732 |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21525354 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 37311534 | ||
| Pubmed | HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability. | 3.53e-05 | 4 | 85 | 2 | 25326330 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 15574327 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 7534311 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 35235356 | ||
| Pubmed | Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis. | 3.53e-05 | 4 | 85 | 2 | 17290217 | |
| Pubmed | Testicular expression of TDRD1, TDRD5, TDRD9 and TDRD12 in azoospermia. | 3.53e-05 | 4 | 85 | 2 | 32059713 | |
| Pubmed | Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc. | 3.53e-05 | 4 | 85 | 2 | 23671107 | |
| Pubmed | Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B. | 3.53e-05 | 4 | 85 | 2 | 17242184 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 9457912 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 19424180 | ||
| Pubmed | Ribosomes guide pachytene piRNA formation on long intergenic piRNA precursors. | 3.53e-05 | 4 | 85 | 2 | 32015435 | |
| Pubmed | Gasdermin D pore structure reveals preferential release of mature interleukin-1. | 3.53e-05 | 4 | 85 | 2 | 33883744 | |
| Pubmed | 3.95e-05 | 27 | 85 | 3 | 19604093 | ||
| Pubmed | 4.92e-05 | 29 | 85 | 3 | 21383078 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 34461100 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 32371889 | ||
| Pubmed | PIDD death-domain phosphorylation by ATM controls prodeath versus prosurvival PIDDosome signaling. | 5.87e-05 | 5 | 85 | 2 | 22854598 | |
| Pubmed | Critical role for inflammasome-independent IL-1β production in osteomyelitis. | 5.87e-05 | 5 | 85 | 2 | 24395792 | |
| Pubmed | ROCK activity affects IL-1-induced signaling possibly through MKK4 and p38 MAPK in Caco-2 cells. | 5.87e-05 | 5 | 85 | 2 | 27173611 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 37730693 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 18316419 | ||
| Pubmed | DNA double strand break repair enzymes function at multiple steps in retroviral infection. | 5.87e-05 | 5 | 85 | 2 | 20003485 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 16723738 | ||
| Pubmed | HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA. | 6.03e-05 | 31 | 85 | 3 | 30279242 | |
| Pubmed | AP2B1 SACS TRPM7 UBE3A KRT83 ZNF84 ATM HERC2 TXLNG ADD3 USP33 WDR47 | 6.71e-05 | 1285 | 85 | 12 | 35914814 | |
| Pubmed | Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin. | 7.29e-05 | 33 | 85 | 3 | 30323974 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 7.79e-05 | 569 | 85 | 8 | 30639242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP VAC14 ZNF276 PI4KA PIEZO1 ARHGAP26 NPRL3 HERC2 ZC3H7B FEM1A BAP1 | 7.89e-05 | 1105 | 85 | 11 | 35748872 |
| Pubmed | Expression of the Bcl-2 protein BAD promotes prostate cancer growth. | 7.98e-05 | 34 | 85 | 3 | 19593445 | |
| Pubmed | 8.03e-05 | 179 | 85 | 5 | 19074885 | ||
| Pubmed | 8.71e-05 | 35 | 85 | 3 | 30257870 | ||
| Pubmed | The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination. | 8.80e-05 | 6 | 85 | 2 | 27528230 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 35749514 | ||
| Pubmed | Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases. | 8.80e-05 | 6 | 85 | 2 | 33852854 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 10966473 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 11409905 | ||
| Pubmed | Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. | 8.80e-05 | 6 | 85 | 2 | 24130709 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 19450528 | ||
| Pubmed | Dietary modulation of the microbiome affects autoinflammatory disease. | 8.80e-05 | 6 | 85 | 2 | 25274309 | |
| Pubmed | USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. | 8.80e-05 | 6 | 85 | 2 | 23486064 | |
| Pubmed | 9.06e-05 | 430 | 85 | 7 | 32581705 | ||
| Interaction | RASGEF1B interactions | 7.43e-06 | 30 | 85 | 4 | int:RASGEF1B | |
| Interaction | LPXN interactions | 9.18e-06 | 115 | 85 | 6 | int:LPXN | |
| Cytoband | 12q13 | 9.67e-06 | 71 | 85 | 4 | 12q13 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.07e-05 | 115 | 57 | 5 | 769 | |
| GeneFamily | Keratins, type II | 8.24e-05 | 27 | 57 | 3 | 609 | |
| GeneFamily | Ubiquitin specific peptidases | 7.31e-04 | 56 | 57 | 3 | 366 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | KNTC1 TDRD5 RIMKLB TRANK1 MOV10L1 CNKSR2 ATM FGD6 TXLNG TDRD12 | 2.56e-06 | 385 | 83 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 2.95e-05 | 406 | 83 | 9 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZNF276 ARID4B TRPM7 GSDMD ARHGAP26 TTC14 DNAH2 CNKSR2 MPHOSPH9 PSTPIP2 FGD6 EPB41L1 | 3.10e-05 | 744 | 83 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | NK cells, NK.MCMV7.Sp, CD3-,NK1.1+, Spleen, avg-3 | 3.24e-05 | 411 | 83 | 9 | GSM538312_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CUL2 KNTC1 TDRD5 RIMKLB TRANK1 TAF9B MOV10L1 CNKSR2 ATM FGD6 TXLNG TDRD12 | 7.91e-05 | 820 | 83 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | 1.36e-04 | 387 | 83 | 8 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 1.59e-04 | 396 | 83 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.67e-04 | 298 | 83 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SACS UBE3A ARHGAP26 MOV10L1 ADAMTS16 ATM THSD7B TXLNG ADD3 WDR47 TDRD12 | 2.12e-04 | 776 | 83 | 11 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 2.46e-04 | 143 | 83 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.35e-06 | 182 | 85 | 6 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.44e-06 | 184 | 85 | 6 | e04cabff33a8e36967622ec3e5b37b89afa7e148 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 153 | 85 | 5 | 2a94092937267cd2282452dfde3d328d763d4294 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 153 | 85 | 5 | ad33c81fe6ac10e7c263d42541aae0d796923bad | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 154 | 85 | 5 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 157 | 85 | 5 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 166 | 85 | 5 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.14e-05 | 85 | 85 | 4 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.14e-05 | 85 | 85 | 4 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 177 | 85 | 5 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.87e-05 | 186 | 85 | 5 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.87e-05 | 186 | 85 | 5 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 190 | 85 | 5 | ce049630ed69d31f00acbc1b5b0896efc592121f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.51e-05 | 194 | 85 | 5 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | distal-Hematologic-Natural_Killer_T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.69e-05 | 196 | 85 | 5 | 05d2a15ba702b07ef59c55891a06da02cdd15f7f | |
| ToppCell | distal-Hematologic-Natural_Killer_T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.78e-05 | 197 | 85 | 5 | 5cb1b45f5dc8fbd9e54db9c943450ce2cc7000e4 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | 580fbf9fcb78357a081e5f5af06113ca33d44581 | |
| Computational | Neighborhood of MLL | 7.96e-05 | 174 | 45 | 6 | GCM_MLL | |
| Computational | Neighborhood of PTK2 | 3.30e-04 | 145 | 45 | 5 | GCM_PTK2 | |
| Drug | ATBI | 4.83e-07 | 18 | 83 | 4 | CID000505862 | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 6.66e-07 | 199 | 83 | 8 | 5817_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A | 6.80e-06 | 193 | 83 | 7 | 1412_DN | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.03e-06 | 198 | 83 | 7 | 914_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; PC3; HT_HG-U133A | 8.30e-06 | 199 | 83 | 7 | 7249_UP | |
| Drug | melicopicine | 1.31e-05 | 2 | 83 | 2 | CID000101253 | |
| Drug | tebuquine | 1.31e-05 | 2 | 83 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 1.31e-05 | 2 | 83 | 2 | CID000460896 | |
| Drug | sulfonamide-3 | 3.93e-05 | 3 | 83 | 2 | CID009847197 | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A | 6.52e-05 | 188 | 83 | 6 | 1865_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 6.71e-05 | 189 | 83 | 6 | 6997_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 7.12e-05 | 191 | 83 | 6 | 4289_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 7.54e-05 | 193 | 83 | 6 | 5839_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 3717_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A | 7.75e-05 | 194 | 83 | 6 | 1437_DN | |
| Drug | phentolamine; Up 200; 11.5uM; MCF7; HT_HG-U133A_EA | 7.75e-05 | 194 | 83 | 6 | 1138_UP | |
| Drug | Lactupicrin | 7.84e-05 | 4 | 83 | 2 | CID000174880 | |
| Drug | lactucin | 7.84e-05 | 4 | 83 | 2 | CID000442266 | |
| Drug | pyriproxyfen | 7.85e-05 | 23 | 83 | 3 | CID000091753 | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.21e-05 | 196 | 83 | 6 | 874_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.21e-05 | 196 | 83 | 6 | 1054_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2110_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2755_DN | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 7252_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 4556_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; HL60; HG-U133A | 8.44e-05 | 197 | 83 | 6 | 1430_DN | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; HL60; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2444_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 5811_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 5815_DN | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 5413_DN | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; HL60; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 1861_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 4788_DN | |
| Drug | quercetin dihydrate; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.68e-05 | 198 | 83 | 6 | 917_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 7313_UP | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 5363_UP | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; PC3; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 4603_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 7398_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 3079_DN | |
| Drug | sulfur mustard | 1.14e-04 | 130 | 83 | 5 | CID000010461 | |
| Drug | AC1NSBNC | 1.30e-04 | 5 | 83 | 2 | CID005357915 | |
| Disease | MONILETHRIX | 1.92e-08 | 3 | 80 | 3 | 158000 | |
| Disease | Beaded hair | 1.92e-08 | 3 | 80 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 1.92e-08 | 3 | 80 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 7.66e-08 | 4 | 80 | 3 | C0546966 | |
| Disease | hair disease (is_implicated_in) | 7.26e-06 | 2 | 80 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Ovarian Serous Adenocarcinoma | 3.27e-05 | 23 | 80 | 3 | C1335177 | |
| Disease | oral squamous cell carcinoma (biomarker_via_orthology) | 4.34e-05 | 4 | 80 | 2 | DOID:0050866 (biomarker_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.90e-04 | 41 | 80 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.90e-04 | 41 | 80 | 3 | C0858252 | |
| Disease | pancreatic cancer (is_implicated_in) | 2.49e-04 | 112 | 80 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Gout | 2.58e-04 | 9 | 80 | 2 | C0018099 | |
| Disease | hair colour measurement | 2.64e-04 | 615 | 80 | 8 | EFO_0007822 | |
| Disease | osteoarthritis | 3.50e-04 | 222 | 80 | 5 | MONDO_0005178 | |
| Disease | hypertension (implicated_via_orthology) | 4.14e-04 | 128 | 80 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | Pulmonary Thromboembolisms | 4.71e-04 | 12 | 80 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 4.71e-04 | 12 | 80 | 2 | C0034065 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 4.71e-04 | 12 | 80 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | chronic kidney disease (is_implicated_in) | 6.47e-04 | 14 | 80 | 2 | DOID:784 (is_implicated_in) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.15e-04 | 148 | 80 | 4 | C0279702 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.20e-03 | 19 | 80 | 2 | DOID:2876 (is_marker_for) | |
| Disease | epilepsy (biomarker_via_orthology) | 1.47e-03 | 21 | 80 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 1.62e-03 | 22 | 80 | 2 | EFO_0009312 | |
| Disease | portal hypertension (biomarker_via_orthology) | 1.62e-03 | 22 | 80 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | Degenerative polyarthritis | 2.09e-03 | 93 | 80 | 3 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 2.09e-03 | 93 | 80 | 3 | C0086743 | |
| Disease | Myocardial Infarction | 2.22e-03 | 95 | 80 | 3 | C0027051 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 2.29e-03 | 96 | 80 | 3 | EFO_0009369 | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.44e-03 | 27 | 80 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.57e-03 | 100 | 80 | 3 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Pancreatic Neoplasm | 2.57e-03 | 100 | 80 | 3 | C0030297 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 2.62e-03 | 28 | 80 | 2 | DOID:3717 (is_marker_for) | |
| Disease | prostate carcinoma in situ (is_marker_for) | 2.62e-03 | 28 | 80 | 2 | DOID:8634 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSSLRFLKCCYTKLP | 571 | Q8NAT2 | |
| KDEKYSPKNCKLRRL | 651 | Q4LE39 | |
| LRKCLKDEDPYVRKT | 126 | P63010 | |
| VKGEKLTRCKLASLY | 131 | Q9UEY8 | |
| KPRYKCVNLSIKDIL | 51 | P57764 | |
| KICEVYSKKSPVSLD | 186 | Q8N8E3 | |
| KYSPKELLALLKCVE | 626 | Q92560 | |
| LRKCLKDEDPYVRKT | 126 | Q10567 | |
| KYRELASKKCSHLPK | 1086 | Q8TE57 | |
| SIYPKSELLEKAAKC | 326 | Q9UPM8 | |
| LCLTKDESKRPKYKE | 346 | P45985 | |
| RYGKDLLNLSRKKPC | 51 | Q9H939 | |
| YKKTESDLLPCKAEE | 121 | Q08116 | |
| PAKKKYLCELCLDDV | 226 | Q5VWQ8 | |
| SPSACYKLFREKQKE | 506 | Q6TGC4 | |
| AKKYKSAICRVTLLD | 91 | Q9H4G0 | |
| KNLYLSCVLKDDKPT | 181 | P01584 | |
| KPLRYKRVDKVCISS | 176 | Q9BXT6 | |
| LKLPRYSCKQVLEEK | 4766 | O95714 | |
| RIKLEKLKCDYVSTS | 506 | Q5HYC2 | |
| LKKDVDCAYLRKSDL | 211 | O43790 | |
| KEPLETTCFYRDKKL | 66 | Q8TE12 | |
| KKLRKSLICESLIYT | 106 | Q9H114 | |
| PKCKLARDLKEAYDS | 196 | Q12980 | |
| ECRLAAKLLAKYKSL | 246 | Q01415 | |
| CISELNLYKSKDPKE | 51 | Q99550 | |
| YPKGDERKKACLSAL | 1751 | P42356 | |
| VALKKDVDCAYLRKS | 41 | A6NCN2 | |
| FKKPIEEVKSYLRCI | 1906 | P50748 | |
| EGKTFYSKKDRPLCK | 436 | Q9NR12 | |
| RLEKLGCEPKLEKYL | 71 | Q9NZK7 | |
| PDLKRIKKVYCCDLT | 266 | P52757 | |
| KYIQKETECLRIAKP | 66 | Q13315 | |
| ESSDYSVPCKRKKIE | 376 | Q13315 | |
| KPIESDSKDLCYKDR | 46 | Q5TD97 | |
| ICPKDTYSDLKSRDK | 596 | Q96SD1 | |
| VTKKGKSYLALRDLC | 331 | Q68DX3 | |
| CLAARALDKNKIPYK | 641 | Q9BSK4 | |
| KAPELLAKYCDNLLK | 386 | Q13617 | |
| KSPELFLCYKRGRDK | 81 | Q5VZ89 | |
| PQLLDCDKVKSSLYK | 536 | Q6IS24 | |
| SALPQYKKKITDRCF | 21 | Q6UWE3 | |
| SKTDKRLLYCIKADP | 881 | P13612 | |
| RCSKPAKYKKLLFSL | 3971 | Q9P225 | |
| QDDIKILKSLPCYKS | 3401 | Q9NZJ4 | |
| YRKAKTITQREKDCP | 681 | Q68D06 | |
| RDSPKCYKLTDKTVI | 66 | P20618 | |
| ESCPLYKKLRLSTDT | 146 | P42575 | |
| LKKDVDCAYLRKSDL | 216 | P78385 | |
| KACAKYKLDRGDPIL | 401 | Q4G0U5 | |
| CLTAPNYRLKSLIKK | 121 | Q9HBM6 | |
| LTAVLPCLAYDDRKK | 301 | Q08AM6 | |
| PCLAYDDRKKSIKEV | 306 | Q08AM6 | |
| LFLKDYSPKLKRMCE | 316 | Q7Z494 | |
| RAKKFSLYCTKPVTL | 121 | Q587J7 | |
| ACLPYIDFKRLKEKR | 191 | Q9Y581 | |
| TCRLEKPAKYDDIKK | 246 | P04406 | |
| TPFRKAKALYACKAE | 756 | Q9UNA1 | |
| PEFKIDRASECRKKY | 621 | Q8WXI2 | |
| QDTFKTCKEYLRPLK | 46 | Q86WR6 | |
| TCKEYLRPLKKFLRK | 51 | Q86WR6 | |
| KDDYSKLCLLLTLPR | 131 | O94967 | |
| KALELYKINAKLCDP | 71 | Q05086 | |
| IKEKRETATLKCYPI | 41 | A0A0A6YYD4 | |
| KLCLLSTKYLSRQKP | 186 | Q14587 | |
| TYCSEKKIPFKILLL | 286 | Q96MW7 | |
| LTIKTRSKCDLYGEK | 151 | Q6ZV73 | |
| KKLRCEREELPTIYK | 421 | Q8N554 | |
| PEEKLAALCKKYADL | 111 | Q9BZA5 | |
| YEKTQIKEKDRCPLS | 566 | Q96N46 | |
| RDCPNKKAIYASKAV | 1246 | P47989 | |
| YPQKEILRALKAKCC | 21 | Q9ULI2 | |
| RTDKKPALCKSYQKL | 181 | Q9Y2K6 | |
| IELPKKRELCKFYIT | 416 | Q9UPT8 | |
| LYECSECRKRFSKKP | 206 | P51523 | |
| KRSYIIKCIEDIKRP | 591 | Q9UPU5 | |
| LKLKKDTSRPYECSE | 306 | Q9UDV6 | |
| IFIIKCSRETEKKYP | 2146 | Q92508 | |
| PKITADKRYKCSLCE | 206 | O60765 | |
| SRKKEKCQDSDLYPL | 901 | Q9C0I4 | |
| AKTYLECKEPTLSLK | 1761 | O15050 | |
| TPEEKLAALCKKYAD | 151 | Q9NUQ3 | |
| SYTEGLKKKCADPDL | 101 | O95801 | |
| LKKKCADPDLNAVLY | 106 | O95801 | |
| CRKLKLPDLKRNDYT | 1816 | Q96QT4 | |
| LLKDLYKCSEKDSIR | 481 | Q9H3U1 | |
| RTDKKPAICKSYLKL | 221 | Q8TEY7 | |
| VVEPDKDLKYCSAKA | 706 | Q9UGR2 | |
| DAVRYLCKKDATKEP | 206 | Q8N402 | |
| LKKDVDCAYLRKSDL | 211 | Q14533 | |
| LPDELYFCKKLKTLK | 721 | Q8TDW0 | |
| KCLTKDYEKRPTVSE | 266 | Q8NEV4 |